The Peter Attia Drive cover image

#272 ‒ Rapamycin: potential longevity benefits, surge in popularity, unanswered questions, and more | David Sabatini, M.D., Ph.D. and Matt Kaeberlein, Ph.D.

The Peter Attia Drive

CHAPTER

Exploring Rapamycin and mTOR Inhibition

This chapter examines the potential effects of rapamycin on COVID-19 severity and long COVID symptoms, suggesting benefits worth investigating further. It discusses the complexities of mTOR inhibition, comparing rapamycin's action to dietary practices and other inhibitors, along with implications for longevity. The conversation highlights gaps in research, challenges in clinical trials, and the intricate relationship between mTOR, autophagy, and aging.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner